Mergers & acquisitions
Danish company Ambu plopped down $265M to acquire Germany-based Invendo Medical, a privately-held medtech company that develops single-use high definition endoscopy products.
WuXi AppTec, a China CRO/CMO, will acquire ResearchPoint Global, of Texas, a global clinical-stage contract research company, to extend the reach of its own clinical CRO coverage.
TPG Capital has acquired all the outstanding shares of Exactech common stock for $42 per share.
Two privately-held biotechs have merged to tackle recurrent C. difficile infections.
GIMDx of Carlsbad, California acquired exclusive China OEM and distribution rights to oncology diagnostic products made by IncellDx, a Menlo Park company.
Two factors have increased speculation that Smith & Nephew may be ready for a takeover.
Allergan is a good example of how many mergers and acquisitions over a very short period of time created a large, international company.
WuXi AppTec will acquire a global clinical-stage contract research company, ResearchPoint Global, of Austin, Texas.
Pfizer has increased its stake in Rhythm Pharmaceuticals.
Sachem Head Capital Management is pushing for that company to break up into small entities in order to increase shareholder value.
PRESS RELEASES